Galantamine versus donepezil in Chinese patients with Alzheimer’s disease: results from a randomized, double-blind study

BACKGROUND: Acetylcholinesterase inhibitors are considered standard of care for Alzheimer’s disease in many countries. Galantamine is an acetylcholinesterase inhibitor that may also act via allosteric modulation of nicotinic acetylcholine receptors. Therefore, it may provide benefits compared with o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhenxin, Yu, Lu, Gaudig, Maren, Schäuble, Barbara, Richarz, Ute
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518285/
https://www.ncbi.nlm.nih.gov/pubmed/23233806
http://dx.doi.org/10.2147/NDT.S38747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518285/
https://www.ncbi.nlm.nih.gov/pubmed/23233806
http://dx.doi.org/10.2147/NDT.S38747

Ejemplares similares